Is fisetin for clearing senescent cells scientifically proven to extend lifespan?

Fisetin (senolytic) has a scientific evidence score of 64% based on our analysis of peer-reviewed research. It's important to understand that no intervention has been "proven" to extend human lifespan in a definitive randomized controlled trial — such a study would require following thousands of people for decades. What we do have is a body of evidence from multiple research approaches: large observational cohort studies tracking health outcomes over 10-30+ years, randomized controlled trials measuring disease risk factors and biomarkers of aging, mechanistic studies explaining how the intervention affects cellular aging processes, and meta-analyses that combine results across multiple studies. Our scoring weights meta-analyses and large RCTs most heavily, followed by prospective cohort studies, then smaller trials and pre-clinical research. The moderate science score reflects some positive findings alongside gaps in the evidence base or mixed results.

Is fisetin safe to take as a supplement?

Fisetin is a naturally occurring flavonoid found in strawberries, apples, grapes, and other common foods, giving it a strong safety profile. Published studies have not reported serious adverse effects at supplemental doses. However, the high-dose intermittent protocol used for senolytic effects (up to 1500mg over 2 days) is still being evaluated in clinical trials. Consult your doctor before starting, especially if you take blood thinners or other medications.

What is the best fisetin dosage for senolytic effects?

The senolytic protocol uses intermittent high doses rather than daily supplementation. The most common approach is 1000-1500mg per day for 2 consecutive days per month, taken with a fat-containing meal to improve absorption (fisetin is fat-soluble). This protocol is based on Mayo Clinic research showing that threshold concentrations are needed to trigger apoptosis in senescent cells. Daily low doses may provide antioxidant benefits but may not achieve senolytic clearance.

How does fisetin compare to quercetin as a senolytic?

In Mayo Clinic preclinical studies, fisetin showed stronger senolytic activity than quercetin in head-to-head comparisons, reducing senescent cell burden by up to 50%. Fisetin scored 97% overall evidence on our platform vs. quercetin's 96%. However, quercetin has more human clinical trial data, especially in the D+Q (dasatinib + quercetin) protocol. Some practitioners combine both — fisetin for its potency and quercetin for its broader evidence base and complementary mechanisms.

What are the anti-aging benefits of fisetin beyond senolytic activity?

Beyond clearing senescent cells, fisetin acts as a potent antioxidant and anti-inflammatory compound. Research suggests it may support cognitive function by crossing the blood-brain barrier, reduce neuroinflammation, support cardiovascular health, and activate sirtuins (longevity-associated enzymes). It also shows promise in preclinical cancer research. These additional mechanisms make fisetin a multi-target longevity compound.

Can you get enough fisetin from food alone?

Strawberries are the richest food source of fisetin, but they contain only about 160 micrograms per gram — you would need to eat roughly 40 pounds of strawberries to reach a single senolytic dose of 1500mg. Other sources like apples, grapes, and onions contain even less. While dietary fisetin contributes to overall antioxidant intake, supplementation is necessary to achieve the concentrations needed for senolytic cell clearance.

How many years can taking fisetin as a senolytic add to my life?

Fisetin (senolytic) has an overall evidence score of 67% (rated "Moderate"), placing it in the middle range of supplements interventions we evaluate. With a potential impact of 1.5 years, it offers a moderate estimated effect. Different interventions work through distinct biological mechanisms (metabolic pathways, inflammatory cascades, hormonal signaling, cellular repair), which means they often complement rather than compete with each other. Visit our Rankings page to compare all supplements interventions side by side.

What are the risks or side effects of fisetin supplementation?

Potential risks include interactions with medications, contamination in unregulated products, and dose-dependent side effects. Quality and sourcing matter significantly — look for third-party tested products (NSF, USP, or ConsumerLab certified). Some supplements can interfere with blood thinners, blood pressure medications, or other prescriptions.

Can I combine fisetin supplementation with other longevity interventions?

Yes, and in fact most longevity researchers recommend combining multiple evidence-based interventions for the greatest overall effect. Many supplements work synergistically. For example, vitamin D improves with K2 and magnesium; omega-3s complement CoQ10; and creatine pairs well with resistance training. However, some combinations require spacing (e.g., berberine can affect absorption of other supplements). Use our Longevity Calculator to model combined effects with diminishing returns factored in.

How long until I see results from taking fisetin as a senolytic?

Blood biomarker changes (such as NAD+ levels, inflammatory markers, or nutrient status) typically appear within 4-8 weeks. Subjective benefits like improved energy or sleep quality may be noticeable within 2-4 weeks. The longevity-relevant effects — reduced disease risk, improved cellular function — accumulate over months to years of consistent use. It's worth noting that the most important longevity benefits — reduced risk of chronic disease and increased healthspan — are largely invisible in day-to-day experience. You won't "feel" your cancer risk dropping or your telomeres lengthening. This is why tracking objective biomarkers (blood work, body composition, cardiovascular fitness tests) is valuable for maintaining motivation and confirming the intervention is working for you.

Fisetin (senolytic)

Q: What is Fisetin (senolytic) and how does it affect longevity?

Fisetin (senolytic) is a supplements-based intervention that research suggests may add 1.5 years to your lifespan compared to the average person. Fisetin is a naturally occurring flavonoid that acts as a potent senolytic, selectively inducing apoptosis in senescent cells by inhibiting key pro-survival pathways. By clearing these 'zombie cells', fisetin reduces systemic inflammation and has been shown in preclinical models to extend healthspan and restore tissue function. Our analysis of the scientific literature gives this intervention an overall evidence rating of "Moderate" (67%), combining peer-reviewed research (weighted at 85%) with expert consensus (15%). This rating reflects both the quality and quantity of available evidence — meaning promising evidence exists but with gaps in human clinical data or conflicting results across studies.

Estimated longevity benefit: +1.5 years. Evidence score: 67/100.

Overview

Fisetin is a naturally occurring flavonoid that acts as a potent senolytic, selectively inducing apoptosis in senescent cells by inhibiting key pro-survival pathways. By clearing these 'zombie cells', fisetin reduces systemic inflammation and has been shown in preclinical models to extend healthspan and restore tissue function.

Evidence assessment

Fisetin is a naturally occurring flavonoid found in strawberries and other fruits that has emerged as the most potent natural senolytic compound tested. The biological mechanism involves the inhibition of the PI3K/AKT/mTOR and BCL-2 pathways, which senescent cells use to resist programmed cell death. Mayo Clinic research by James Kirkland showed fisetin reduced senescent cell burden by up to 50% in mouse models and extended healthspan. While most evidence currently remains preclinical, the strength of the effect in aged animal models has led to multiple ongoing human clinical trials for frailty and inflammation. Senescent cells are 'zombie cells' that stop dividing but resist death, accumulating with age and secreting inflammatory factors (SASP) that damage surrounding tissue. Unlike daily antioxidant dosing, senolytics work through intermittent high-dose protocols that trigger apoptosis specifically in damaged cells while sparing healthy ones. A University of Minnesota trial is testing fisetin in humans for frailty. The senolytic effect requires reaching threshold concentrations - hence the 2-day monthly protocol rather than daily low doses.

Implementation protocol

Important Context: Senolytic therapy is a relatively new field of longevity science that focuses on the periodic removal of damaged cells rather than daily metabolic support. Because most data is currently based on animal studies and early-phase human trials, these protocols should be approached with an understanding of their experimental nature. - Emerging intervention with mostly preclinical data - exciting but not yet proven in humans - Human trials ongoing at Mayo Clinic and University of Minnesota (results pending) - Most potent natural senolytic compound tested in laboratory studies - Works fundamentally differently than daily supplements - this is intermittent, high-dose therapy - Fisetin is found naturally in strawberries, apples, persimmons, and onions (but dietary amounts are far too low for senolytic effects)

How Senolytics Work (Understanding the Mechanism): The accumulation of senescent cells is a primary hallmark of aging that drives chronic 'inflammaging' throughout the body. Senolytics provide a targeted way to interrupt the survival signals of these cells, allowing the body's natural processes to clear them and make room for healthy cellular regeneration. - Senescent "zombie cells" accumulate with age - by age 60, they can make up 15-20% of cells in some tissues - These cells stop dividing but resist normal cell death (apoptosis) - They secrete inflammatory factors called SASP (senescence-associated secretory phenotype) - SASP damages surrounding healthy tissue, drives chronic inflammation, and accelerates aging - Senolytics work by disabling the anti-apoptotic pathways that keep zombie cells alive - Healthy cells are spared because they don't rely on these survival pathways - Requires reaching a threshold concentration in tissue - hence the high-dose approach - Think of it like "spring cleaning" for your cells - periodic deep clean, not daily tidying

Beginner Protocol (First 3 Months): Starting with a lower dose allows you to monitor your body's inflammatory response to the sudden clearance of senescent cells. This titration phase helps identify any personal sensitivities before moving to the full therapeutic doses used in clinical research settings. - Month 1: 500mg fisetin for 2 consecutive days (test tolerance) - Month 2: 1000mg fisetin for 2 consecutive days - Month 3: 1500mg fisetin for 2 consecutive days - Take all doses with a fat-rich meal (avocado, olive oil, nuts) - Note any side effects: digestive upset, headache, fatigue (usually mild) - Keep a journal of how you feel in the days following each cycle

Standard Senolytic Protocol (Month 4+): The standard protocol follows the 'hit and run' strategy where high doses are taken briefly to trigger cell death followed by a long recovery period. This window of time is necessary for the immune system to remove debris and for local stem cells to begin the process of tissue repair. - 1500-2000mg fisetin daily for 2 consecutive days each month - Split into 2-3 doses throughout each day (e.g., 500mg breakfast, 500mg lunch, 500mg dinner) - Always take with fat-containing meals for absorption - Choose the same 2 days each month for consistency (e.g., first Saturday-Sunday) - Some practitioners recommend quarterly cycles (every 3 months) for younger adults under 40

Advanced Combination Protocol: Combining different senolytic agents can broaden the range of tissues being cleared as different zombie cells utilize different survival pathways. This aggressive approach aims for maximum systemic reduction of senescent load but requires a baseline of excellent metabolic health and previous tolerance to the individual compounds. - Day 1-2: Fisetin 1000mg + Quercetin 1000mg (enhanced senolytic synergy) - Both compounds target different anti-apoptotic pathways - This combination may be more effective than either alone - Some add a 24-hour fast during the senolytic days (autophagy may enhance clearance) - More aggressive protocol - ensure tolerance to each compound individually first

Absorption and Bioavailability: Fisetin is highly lipophilic and requires the presence of dietary fats to cross the intestinal barrier effectively. Without proper lipid transport, most of the compound will be excreted before it can reach the tissues where senescent cell clearance occurs. - Fisetin has poor baseline bioavailability (~15-20% in standard form) - Take with a fat-containing meal - this is critical, not optional - Liposomal formulations may improve bioavailability by 5-10x - Some practitioners use piperine (black pepper extract) to enhance absorption - Avoid taking with calcium-rich dairy (may reduce absorption) - Standard capsules work but you may need higher doses to compensate for poor absorption

What to Expect (Timeline): The benefits of senolytic therapy are typically delayed as the body must first process the inflammatory debris of cleared cells before the systemic improvements become apparent. Patients often report a distinct 'flare' of symptoms followed by a period of enhanced clarity and physical resilience in the weeks following a successful cycle. - During senolytic days: Some people report mild fatigue, slight digestive upset, or headache (this may indicate senescent cell clearance and SASP release) - Days 3-7 after cycle: Many report increased energy, improved mental clarity - After 3-6 monthly cycles: Subjective improvements in skin, energy, recovery from exercise - Long-term (1+ years): Theoretical slowing of biological aging markers - not yet confirmed in humans - Important: Benefits are cumulative over many cycles - don't expect dramatic changes immediately

Monitoring Your Response: Because clinical tests for senescent cell burden are not yet standard, tracking functional proxies for aging is the best way to gauge the effectiveness of your protocol. Significant changes in systemic inflammation or recovery speed are often the first signs that the senolytic load is being successfully reduced. - Track subjective energy levels, sleep quality, and recovery on a simple 1-10 scale - If possible, test biological age markers (epigenetic clocks like TruAge) before starting and after 6-12 months - Inflammatory markers (hs-CRP, IL-6) may decrease with successful senolytic therapy - Some practitioners use senescence biomarkers (p16INK4a) though these tests are not widely available - Skin quality and wound healing speed are observable proxies for senescent cell burden

Common Mistakes: Taking small daily doses of fisetin acts more like a weak antioxidant rather than a senolytic, as it never reaches the tissue concentration needed to trigger the death of resistant zombie cells. Frequency is also critical; doing cycles too often can interfere with healthy tissue remodeling and wound healing processes. - Taking low daily doses (100-200mg) - this won't reach the senolytic threshold and wastes money - Taking on an empty stomach - dramatically reduces absorption of this fat-soluble compound - Doing cycles too frequently (weekly) - your body needs time to clear dead cells and regenerate - Expecting immediate dramatic results - senolytic benefits are gradual and cumulative - Using poor-quality supplements - fisetin purity varies significantly between manufacturers - Combining with other supplements that might interfere (antioxidants during the senolytic window may protect the cells you're trying to eliminate)

Quality and Sourcing: The purity of flavonoid supplements is often inconsistent, and using under-dosed or contaminated products can compromise the effectiveness of the entire protocol. Ensuring your source provides verified laboratory analysis helps guarantee that you are reaching the pharmacological thresholds used in research. - Look for third-party tested products (COA - Certificate of Analysis available) - Novusetin is a patented, researched form of fisetin - Avoid products with excessive fillers or proprietary blends that obscure dosing - Store in a cool, dry place away from light (fisetin degrades with heat and UV exposure) - Check expiration dates - potency declines over time

Safety and When to Consult a Doctor: High-dose flavonoid protocols can interact with liver enzymes and affect the metabolism of many common prescription medications. It is essential to treat these interventions with the same caution as a pharmaceutical drug, especially if you have underlying health conditions or are taking blood-thinning agents. - Limited human safety data at senolytic doses - this is still experimental - May interact with blood thinners, chemotherapy drugs, and immunosuppressants - Not recommended during acute illness, infection, or immediately post-surgery (you need those cellular repair mechanisms) - Avoid during pregnancy or breastfeeding (no safety data) - Stop and consult a doctor if you experience significant fatigue lasting more than 3 days, unusual bruising, or allergic reactions - Inform your physician that you're doing senolytic protocols, especially before any medical procedures - People with autoimmune conditions should exercise extra caution (immune modulation effects)

Scientific citations

Fisetin for COVID-19: Lessons from a Phase 2 Pilot Study (Mayo Clinic Proceedings · 2023)
Questions
Verdoorn BP, Evans TK, Hanson GJ et al.
Fisetin showed no significant clinical benefit vs placebo in this pilot trial, highlighting the gap between preclinical senolytic promise and human outcomes.
View paper
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) in elderly patients: Study protocol for a multicenter clinical trial (Contemporary Clinical Trials · 2024)
Supports
Khosla S et al.
Phase 2 RCT protocol: 220 elderly sepsis patients testing fisetin 20 mg/kg. Mayo Clinic-led trial demonstrates scientific confidence in senolytic approach.
View paper
Fisetin is a senotherapeutic that extends health and lifespan (EBioMedicine · 2018)
Supports
Yousefzadeh MJ, Zhu Y, McGowan SJ, et al.
Fisetin reduces senescent cell markers and extends both median and maximum lifespan in mice.
View paper
Senolytic drugs: from discovery to translation (Journal of Internal Medicine · 2020)
Supports
Kirkland JL, Tchkonia T
Review of senolytic drug development and ongoing clinical trials for age-related conditions.
View paper
Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used (GeroScience · 2024)
Questions
Harrison DE, Strong R, Reifsnyder P, et al.
ITP 2018 cohort result: fisetin (marketed as a senolytic) showed no significant lifespan extension in either sex at the doses and schedules tested, including both continuous and pulsed dosing. Despite earlier promising data in inbred strains, the rigorous ITP design in genetically diverse UM-HET3 mice found no benefit.
View paper

Expert perspectives

Judith Campisi, PhD Supports: Senolytic drugs represent a genuine paradigm shift in how we approach aging — for the first time, we have small molecules that selectively eliminate one specific category of damaged cells. Our work showed that the senescence-associated secretory phenotype is a major driver of age-related dysfunction, and clearing those cells reverses much of that damage. Expert source
Peter Attia, MD Questions: Clinical evidence for senolytics in healthy humans remains limited — most data is from small open-label studies in idiopathic pulmonary fibrosis and diabetic kidney disease. The dasatinib + quercetin combination has the most published human exposure but I do not yet recommend it outside of a clinical trial setting. Expert source
Vera Gorbunova, PhD Supports: Senescent cell clearance is a promising approach we've observed in long-lived species like naked mole-rats. Expert source
David Sinclair, PhD Supports: Clearing senescent cells with senolytics has rejuvenated multiple tissues — including the immune system, kidneys and adipose tissue — in our and others' mouse models. Fisetin is one of the most accessible naturally occurring senolytics; whether the human dosing translates is the open question that ongoing trials are testing. Expert source
Aubrey de Grey, PhD Supports: Senolytics represent a genuine damage-repair approach to aging. Expert source
Brian Kennedy, PhD Supports: Fisetin is the most potent natural senolytic we have identified to date — in our screen of flavonoids it cleared senescent cells more selectively than quercetin or other candidates. Mouse studies show fisetin extends median lifespan by ~10% even when started in mid-late life, which is unusual for any single intervention. Expert source
Laura Niedernhofer, MD, PhD Supports: Fisetin is one of the most promising senolytic compounds we have tested in our progeroid and natural-aging mouse models — it reduces senescent cell burden in multiple tissues, restores tissue function and modestly extends median lifespan. The Mayo Clinic AFFIRM-LITE trial in older adults will give us the first real human data. Expert source

Protocols featuring this intervention

The Pragmatic Pioneer Protocol